Related Experiment Video
Updated: Sep 20, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Interdisciplinary Swiss Consensus Recommendations on Management of Advanced Prostate Cancer
Arnoud J Templeton1,2, Vérane Achard3, Dilara Akhoundova4
1Medical Oncology, St. Claraspital, Basel, Switzerland, St. Clara Research Ltd., Basel, Switzerland, and Faculty of Medicine, University of Basel, Basel, Switzerland.
Introduction:
The landscape of diagnosis and treatment of locally advanced and metastatic prostate cancer has seen an unprecedented evolution in recent years. Incorporation of results from pivotal studies is crucial for state-of-the-art counselling of patients and to inform treatment recommendations. However, in daily practice ambiguous situations may occur or various options may seem adequate. Furthermore, specific national regulations, e.g. availability of diagnostic tools and drug approvals, may influence treatment choices. This paper presents the voting results of a Swiss expert panel that convened in August 2024 and discussed selected questions addressed by an international panel of experts during the Advanced Prostate Cancer Conference held in Lugano in April 2024. The objective is to facilitate national harmonization of diagnosis and treatment of locally advanced and metastatic prostate cancer and thereby providing a basis for discussion with individuals with prostate cancer.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Acute Coronary Syndrome IV: Interprofessional Care
Treatment Resistant Cancers
Urinary Tract Calculi III: Medical Management
Aneurysm III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care

